We are live on
!
Find out more
OQS
Occudo Quantitative Strategies Portfolio holdings
AUM
$1.84B
1-Year Est. Return
22.15%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
+$245M
(+29%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
21.19%
Top 10 Holdings %
Top 10 Hldgs %
8.02%
Holding
1,300
New
383
Increased
225
Reduced
257
Closed
427
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$9.28M |
| 2 |
CSX Corp
CSX
|
+$9.14M |
| 3 |
Emerson Electric
EMR
|
+$8.99M |
| 4 |
Xcel Energy
XEL
|
+$8.88M |
| 5 |
Exelon
EXC
|
+$8.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$3.66M |
| 2 |
The Mosaic Company
MOS
|
+$3.64M |
| 3 |
Ulta Beauty
ULTA
|
+$3.63M |
| 4 |
Marvell Technology
MRVL
|
+$3.63M |
| 5 |
Hasbro
HAS
|
+$3.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Consumer Discretionary | 18.16% |
| 3 | Industrials | 16.37% |
| 4 | Consumer Staples | 8.29% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Nuvation Bio
NUVB
$2.14B
| $88.2K | 0.01% |
53,118
-4,083
| -7% | -$8.28K |
|
|
SHCO
827
DELISTED
Soho House & Co
SHCO
| $86.6K | 0.01% |
+13,248
| New | +$78.7K |
|
828
Gevo
GEVO
$355M
| $86.1K | 0.01% |
+55,928
| New | +$106K |
|
|
NPKI
829
NPK International
NPKI
$1.12B
| $83.6K | 0.01% |
21,719
-23,080
| -52% | -$101K |
|
|
ARC
830
DELISTED
ARC Document Solutions, Inc.
ARC
| $83.2K | 0.01% |
+26,244
| New | +$87.7K |
|
831
NextDecade
NEXT
$1.74B
| $81.9K | 0.01% |
16,470
-62,771
| -79% | -$365K |
|
832
Verrica Pharmaceuticals
VRCA
$90.2M
| $81.1K | 0.01% |
+1,248
| New | +$75.5K |
|
|
CELL
833
DELISTED
PhenomeX Inc. Common Stock
CELL
| $79.8K | 0.01% |
68,759
+17,415
| +34% | +$31.8K |
|
|
KZR
834
DELISTED
Kezar Life Sciences
KZR
| $77.7K | 0.01% |
+2,482
| New | +$144K |
|
835
Groupon
GRPN
$1.05B
| $76.9K | 0.01% |
+18,267
| New | +$126K |
|
|
IRD
836
Opus Genetics
IRD
$301M
| $73.6K | 0.01% |
+19,623
| New | +$70.5K |
|
837
Design Therapeutics
DSGN
$826M
| $73K | 0.01% |
+12,652
| New | +$94.6K |
|
838
Heritage Insurance Holdings
HRTG
$915M
| $69.5K | 0.01% |
+22,555
| New | +$58.8K |
|
839
Paysign
PAYS
$517M
| $69.2K | 0.01% |
+19,057
| New | +$65.1K |
|
840
Identive
INVE
$64.8M
| $65.5K | 0.01% |
+10,667
| New | +$78.5K |
|
841
Rush Street Interactive
RSI
$2.9B
| $65.2K | 0.01% |
20,964
-67,712
| -76% | -$260K |
|
|
ICD
842
DELISTED
Independence Contract Drilling, Inc.
ICD
| $64.8K | 0.01% |
19,869
+1,333
| +7% | +$5.13K |
|
843
Quest Resource Holding
QRHC
$27.2M
| $64.6K | 0.01% |
10,528
| – | – |
|
|
ETWO
844
DELISTED
E2open Parent Holdings
ETWO
| $59.9K | 0.01% |
+10,298
| New | +$62.2K |
|
845
BioAtla
BCAB
$5.56M
| $58.2K | 0.01% |
+434
| New | +$78.2K |
|
846
Arqit Quantum
ARQQ
$383M
| $55.4K | 0.01% |
+1,584
| New | +$74.9K |
|
|
KRON
847
DELISTED
Kronos Bio
KRON
| $53.4K | ﹤0.01% |
36,552
+13,035
| +55% | +$25K |
|
|
EMBK
848
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $51.2K | ﹤0.01% |
18,232
-14,932
| -45% | -$55K |
|
|
DBD
849
DELISTED
Diebold Nixdorf Incorporated
DBD
| $50.3K | ﹤0.01% |
+41,944
| New | +$93.3K |
|
850
FTAI Infrastructure
FIP
$405M
| $50.2K | ﹤0.01% |
+16,744
| New | +$50.9K |
|
Similar funds
RP
ABTD
KAM
FCIM
CPSAC
OFS
LOAME
DP
Occudo Quantitative Strategies's Q1 2023 Portfolio in Review
As of Q1 2023, Occudo Quantitative Strategies held 1,300 positions worth $1.1B, up 29% from $859M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Occudo Quantitative Strategies deployed $234M of net new capital in Q1 2023, opening 383 new positions and adding to 225 existing holdings. Its largest new stake was Sherwin-Williams: 40,550 shares worth $9.11M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Ferrari, an estimated $3.66M trimmed.
- Occudo Quantitative Strategies's largest Q1 2023 buy was Sherwin-Williams: 40,550 shares worth $9.11M.
- Occudo Quantitative Strategies added most to Brown-Forman Class B in Q1 2023, an estimated $7.93M increase.
- Occudo Quantitative Strategies's biggest Q1 2023 reduction was Ferrari, cutting an estimated $3.66M.
- Occudo Quantitative Strategies fully exited The Mosaic Company in Q1 2023, selling an estimated $3.64M.
- Occudo Quantitative Strategies's ten largest holdings make up 8% of its $1.1B portfolio in Q1 2023.
- Occudo Quantitative Strategies opened 383 new positions and closed 427 in Q1 2023.
- Occudo Quantitative Strategies's portfolio value rose 29% quarter-over-quarter to $1.1B.
Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.